Subtopic Deep Dive

MicroRNA Biogenesis Pathways
Research Guide

What is MicroRNA Biogenesis Pathways?

MicroRNA biogenesis pathways encompass the canonical pathway involving Drosha/DGCR8 nuclear processing of pri-miRNAs to pre-miRNAs, Dicer cytoplasmic cleavage, and Argonaute loading, alongside non-canonical pathways bypassing these steps.

Primary miRNAs (pri-miRNAs) are transcribed by RNA polymerase II and cleaved by the Drosha-DGCR8 microprocessor complex into precursor miRNAs (pre-miRNAs) (Han et al., 2004, 2166 citations). Pre-miRNAs are exported to the cytoplasm for Dicer processing into mature miRNAs loaded into Argonaute proteins (O’Brien et al., 2018, 4949 citations). Non-canonical pathways produce miRNAs independent of Drosha or Dicer (MacFarlane and Murphy, 2010). Over 100 papers detail these mechanisms.

Curated Papers

Key Challenges

Why It Matters

Dysregulation of miRNA biogenesis pathways alters miRNA levels in cancer, enabling oncogene suppression or tumor suppressor inhibition (Peng and Croce, 2016, 2392 citations). Targeting Drosha or Dicer therapeutically modulates miRNA expression to treat tumors (MacFarlane and Murphy, 2010, 1810 citations). In inflammation-linked cancers, biogenesis defects amplify tumorigenic signaling (Hussain and Harris, 2007, 1076 citations). These pathways offer drug targets like noncoding RNA therapeutics (Winkle et al., 2021, 1488 citations).

Key Research Challenges

Non-canonical pathway identification

Distinguishing non-canonical miRNAs from canonical ones requires advanced sequencing due to Drosha/Dicer independence (Friedländer et al., 2011, 3285 citations). High-throughput methods like miRDeep2 detect novel miRNAs but miss low-abundance non-canonicals (Morin et al., 2008). Validation via CRISPR screens remains limited.

Structural mechanisms of processing

Drosha-DGCR8 complex recognizes pri-miRNA hairpins through unclear structural rules (Han et al., 2004, 2166 citations). Dicer-Argonaute loading efficiency varies by sequence context, complicating predictions (O’Brien et al., 2018). Structural biology data are sparse for disease variants.

Disease-specific dysregulation

Cancer mutations disrupt biogenesis enzymes like Drosha, but pathway-wide effects are hard to quantify (Peng and Croce, 2016). Inflammation alters Dicer expression, linking to tumorigenesis without clear causality (Hwang and Mendell, 2006). Integrating multi-omics data poses computational hurdles.

Essential Papers

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Jacob A. O’Brien, Heyam Hayder, Yara Zayed et al. · 2018 · Frontiers in Endocrinology · 4.9K citations

MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processe...

miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades

Marc R. Friedländer, Sebastian D. Mackowiak, Na Li et al. · 2011 · Nucleic Acids Research · 3.3K citations

microRNAs (miRNAs) are a large class of small non-coding RNAs which post-transcriptionally regulate the expression of a large fraction of all animal genes and are important in a wide range of biolo...

The role of MicroRNAs in human cancer

Yong Peng, Carlo M. Croce · 2016 · Signal Transduction and Targeted Therapy · 2.4K citations

Abstract MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that function in regulation of gene expression. Compelling evidences have demonstrated that miRNA expression is dysregulated in hum...

The Drosha-DGCR8 complex in primary microRNA processing

Jinju Han, Yoontae Lee, Kyu-Hyun Yeom et al. · 2004 · Genes & Development · 2.2K citations

RNase III proteins play key roles in microRNA (miRNA) biogenesis. The nuclear RNase III Drosha cleaves primary miRNAs (pri-miRNAs) to release hairpin-shaped pre-miRNAs that are subsequently cut by ...

MicroRNA: Biogenesis, Function and Role in Cancer

Leigh-Ann MacFarlane, Paul R. Murphy · 2010 · Current Genomics · 1.8K citations

MicroRNAs are small, highly conserved non-coding RNA molecules involved in the regulation of gene expression. MicroRNAs are transcribed by RNA polymerases II and III, generating precursors that und...

Noncoding RNA therapeutics — challenges and potential solutions

Melanie Winkle, Sherien M. El‐Daly, Muller Fabbri et al. · 2021 · Nature Reviews Drug Discovery · 1.5K citations

MicroRNAs in cell proliferation, cell death, and tumorigenesis

Hun‐Way Hwang, Joshua T. Mendell · 2006 · British Journal of Cancer · 1.4K citations

Reading Guide

Foundational Papers

Start with Han et al. (2004, 2166 citations) for Drosha-DGCR8 mechanism, then Friedländer et al. (2011, 3285 citations) for miRDeep2 discovery tool, and MacFarlane and Murphy (2010, 1810 citations) for cancer context.

Recent Advances

O’Brien et al. (2018, 4949 citations) for comprehensive overview; Winkle et al. (2021, 1488 citations) for therapeutic challenges; Peng and Croce (2016, 2392 citations) for cancer dysregulation.

Core Methods

Drosha/DGCR8 cleavage assays, Dicer knockout CRISPR screens, miRDeep2 sequencing analysis, Argonaute IP-MS for loading, hairpin structure prediction (Han et al., 2004; Friedländer et al., 2011).

How PapersFlow Helps You Research MicroRNA Biogenesis Pathways

Discover & Search

Research Agent uses searchPapers('Drosha DGCR8 processing') to retrieve Han et al. (2004), then citationGraph to map 2000+ citing works on microprocessor complex, and findSimilarPapers to uncover non-canonical variants like mirtrons. exaSearch handles semantic queries for 'Dicer-independent miRNA cancer pathways' yielding O’Brien et al. (2018).

Analyze & Verify

Analysis Agent applies readPaperContent on Han et al. (2004) to extract Drosha cleavage rules, verifies claims with CoVe against 10 citing papers, and runs PythonAnalysis to plot miRNA hairpin structures from sequences using BioPython. GRADE grading scores biogenesis model evidence as A-level from 4949-cited O’Brien et al. (2018). Statistical tests confirm pathway conservation across species.

Synthesize & Write

Synthesis Agent detects gaps in non-canonical pathway therapeutics via contradiction flagging between Winkle et al. (2021) and Peng et al. (2016), generates exportMermaid diagrams of canonical vs. non-canonical flows. Writing Agent uses latexEditText for pathway schematics, latexSyncCitations to integrate 20 papers, and latexCompile for publication-ready reviews.

Use Cases

"Analyze miRNA seq data from cancer cells for biogenesis defects using Python"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas/NumPy to quantify Drosha targets from FASTQ via miRDeep2-like pipeline) → matplotlib plots of dysregulated pre-miRNAs vs. controls.

"Write LaTeX review on Drosha-DGCR8 in cancer biogenesis"

Synthesis Agent → gap detection → Writing Agent → latexEditText (draft sections) → latexSyncCitations (add Han 2004, O’Brien 2018) → latexCompile → PDF with biogenesis pathway figure.

"Find code for miRDeep2 miRNA discovery from papers"

Research Agent → searchPapers('miRDeep2') → paperExtractUrls (Friedländer 2011) → paperFindGithubRepo → githubRepoInspect → runnable miRDeep2 Docker pipeline for novel miRNA calling in disease samples.

Automated Workflows

Deep Research workflow scans 50+ papers on 'miRNA biogenesis cancer' via searchPapers → citationGraph → structured report with Drosha/Dicer timelines. DeepScan applies 7-step CoVe to validate non-canonical claims from Friedländer et al. (2011), with GRADE checkpoints. Theorizer generates hypotheses on Dicer inhibitors from O’Brien et al. (2018) + Peng et al. (2016).

Try Doxa for MicroRNA Biogenesis Pathways Research

Frequently Asked Questions

What defines canonical miRNA biogenesis?

Canonical pathway starts with pri-miRNA transcription, Drosha-DGCR8 nuclear cleavage to pre-miRNA, Exportin-5 export, Dicer cleavage, and Argonaute loading (Han et al., 2004; O’Brien et al., 2018).

What methods identify novel miRNAs?

miRDeep2 uses deep sequencing to map novel miRNAs across clades by excising signatures from adapters (Friedländer et al., 2011, 3285 citations). Massively parallel sequencing profiles miRNAs in stem cells (Morin et al., 2008).

Which papers are key for biogenesis?

Han et al. (2004, 2166 citations) defines Drosha-DGCR8 processing; O’Brien et al. (2018, 4949 citations) overviews full pathways; MacFarlane and Murphy (2010, 1810 citations) links to cancer.

What are open problems in miRNA biogenesis?

Quantifying non-canonical contributions in cancer, structural rules for Drosha substrate selection, and therapeutic targeting of biogenesis enzymes without off-target effects (Winkle et al., 2021; Peng and Croce, 2016).